Blood Glucose Monitoring System Market To Reach Us$10.58 Bn By The Year 2022

By Author: Johnny
Total Articles: 114
Comment this article

The blood glucose monitoring systems market is well established owing to the dominance by prominent market players. In 2016, Roche (Switzerland), Abbott (US), LifeScan (US), and Ascensia (Switzerland) held a share of approximately 65% to 70% of the self-monitoring blood glucose systems market whereas, Medtronic (Ireland), Dexcom (US) and Abbott (US) held a share of approximately 95% to 100% of continuous glucose monitoring systems market.

Access Sample Copy of the Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=14912252

The global blood glucose monitoring system market is projected to reach USD 10.58 Billion by 2022 from an estimated USD 8.35 Billion in 2017, at a CAGR of 4.8% during the forecast period.

The market is segmented on the basis of product, testing site, patient care setting, application, and region. Based on product, the market is segmented into self-monitoring blood glucose systems and continuous glucose monitoring systems. The continuous glucose monitoring system segment is expected to grow at the highest CAGR during the forecast period. The high growth in the continuous ...
... glucose monitoring system segment can be primarily attributed to the rising adoption of minimally invasive procedures.

On the basis of testing site, the global market is segmented into fingertip testing and alternate site testing. The fingertip testing segment is expected to account for the largest of the global market and is expected to register the highest CAGR. This can be primarily attributed to the accuracy and high reliability of fingertip testing.

On the basis of patient care setting, the global market is categorized into self/home care and hospital & clinics. The self/home care segment is estimated to account for the largest of the global blood glucose monitoring system market and is expected to register the highest CAGR. This can primarily be attributed to growing diabetic population, and increasing awareness about regular monitoring of glucose levels and increasing product launches enhancing patient comfort when used at home.

Based on application, the market is categorized into type 1 diabetes, type 2 diabetes, and gestational diabetes. The type 2 diabetes segment is estimated to command the largest share of the blood glucose monitoring systems market. The large share can be attributed to increasing incidence of type 2 diabetes, and increasing innovative product launches with less invasive technologies.

Geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this region can primarily be attributed to the favorable reimbursements, awareness programs, rising FDA approvals in the US, and rising prevalence of diabetes in the US and Canada.

The key players in the global blood glucose monitoring system market are Roche (Switzerland), Abbott (US), LifeScan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US).

Objectives of the Study

To define, describe, and forecast the global market by product, testing site, patient care setting, application, and region

To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)

To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

To forecast size of market segments with respect to the four main regions, namely, North America (US and Canada), Europe (Germany, UK, France, and Rest of Europe), Asia Pacific (China, Japan, India, and Rest of APAC), and the Rest of the World (Latin America and Middle East & Africa)

To strategically analyze the market structure and profile key players of the global market and comprehensively analyze their core competencies

To track and analyze company developments such as partnerships, agreements and collaborations; expansions; acquisitions; and product launches in the market

Download PDF Brochure: @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=14912252

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.